Agilon Health (AGL) returns
Agilon Health returns over 5 years
$1,000 invested in Agilon Health five years ago was worth $138.61 at the close on October 30, 2026, with dividends reinvested: an average return of -32.6% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +6.7% | — | $1,067 | -0.9% |
| 3 months | -12.2% | — | $877.52 | +2.1% |
| Year to date | +393.1% | — | $4,931 | +11.7% |
| 1 year | +324.5% | — | $4,245 | +12.4% |
| 3 years | -80.9% | -42.4% | $191.22 | +88.5% |
| 5 years | -86.1% | -32.6% | $138.61 | +76.0% |
Agilon Health return by calendar year
| Year | AGL | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +393.1% | +11.7% | +381.4% |
| 2025 | -63.8% | +17.7% | -81.5% |
| 2024 | -84.9% | +24.9% | -109.7% |
| 2023 | -22.2% | +26.2% | -48.4% |
| 2022 | -40.2% | -18.2% | -22.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: AGL financials
No forecast, no recommendation. This page describes Agilon Health from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.